Sort by
Refine Your Search
-
to research protocols, supporting data collection, and maintaining a safe environment for participants and staff. Educate participants on exercise principles, device usage, and protocol adherence; communicate
-
Manufacturing and analytical development for cellular immunotherapy products. This role involves performing QC assays, release tests, and assay development tasks, including cell viability, Flow Cytometry, ELISA
-
modify protocols. Write standard operating procedures and reports. Maintain records of work performed, including results and methodology; utilizing records may calculate, graph, and compile data. Develop
-
drug development, with strong potential for publication in high-impact journals. Our research aims to uncover fundamental mechanisms of leukemogenesis and solid tumor progression, with a particular
-
pioneering the development of neural stem cell (NSC) and extracellular vesicle (EV)-based therapies for neurodegenerative conditions, including traumatic brain injury (TBI), chemotherapy-related cognitive
-
. · Perform comprehensive molecular validation and phenotyping techniques. · Support manuscript development, figure design, and integration of interim research findings to drive research progress. Your
-
Administrator generally works pacific time zone business hours. Position Summary: Coordinates and develops coverage analyses and budgets for both industry sponsored and non-industry sponsored clinical trials
-
modify protocols. Write standard operating procedures and reports. Maintain records of work performed, including results and methodology; utilizing records may calculate, graph, and compile data. Develop
-
. The ideal candidate will have experience in developing LC-MS-based methods, troubleshooting instrumentation, processing complex data, and creating SOPs for metabolite and lipid identification. As a successful
-
candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA methylation